Diversified Healthcare Trust (DHCNL) EBITDA (2009 - 2026)

Diversified Healthcare Trust (DHCNL) has reported EBITDA for 18 consecutive years, with -$4.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 90.86% year-over-year to -$4.7 million; the trailing twelve-month figure through Jun 2026 stood at -$172.8 million (up 16.82% YoY), and the FY2025 full-year result was -$261.1 million, down 63.45% from the prior year.
• EBITDA rose to -$4.7 million in Q2 2026 per DHCNL's latest filing, from -$13.0 million in the prior quarter.
• Across five years, EBITDA topped out at $352.9 million in Q1 2022 and bottomed at -$124.8 million in Q3 2025.
• Historically, EBITDA has averaged $10.7 million across 5 years, with a median of -$8.8 million in 2026.
• The sharpest annual moves came in 2023 and 2024: EBITDA jumped 3913.78% in 2023, then plunged 206.44% in 2024.
• Over 5 years, EBITDA stood at $49.9 million in 2022, then advanced by 5.49% to $52.6 million in 2023, then sank by 193.06% to -$49.0 million in 2024, then soared by 38.07% to -$30.3 million in 2025, then surged by 84.52% to -$4.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$4.7 million, -$13.0 million, and -$30.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.